Recent study evaluated hemolysis in patients supported with the Impella 5.5 percutaneous left ventricular assist device in a ...

March 27, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, the global leader in heart recovery, will feature the latest evidence demonstrating the survival benefit of Impella® heart pump ...